Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31380) 31380
Publication (3964) 3964
Newsletter (972) 972
Book Review (291) 291
Book Chapter (160) 160
Conference Proceeding (39) 39
Dissertation (32) 32
Book / eBook (24) 24
Magazine Article (20) 20
Newspaper Article (11) 11
Data Set (4) 4
Government Document (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18722) 18722
animals (14016) 14016
index medicus (13006) 13006
macrophages (10444) 10444
mice (9854) 9854
immunology (8047) 8047
female (7759) 7759
male (7231) 7231
colony-stimulating factor (5785) 5785
cells, cultured (5362) 5362
inflammation (5145) 5145
cytokines (4750) 4750
expression (4394) 4394
cell biology (4233) 4233
hematology (3952) 3952
adult (3912) 3912
dendritic cells (3822) 3822
middle aged (3478) 3478
macrophages - metabolism (3349) 3349
oncology (3309) 3309
mice, inbred c57bl (3258) 3258
granulocyte-macrophage colony-stimulating factor - pharmacology (3226) 3226
macrophages - immunology (3170) 3170
research (3122) 3122
macrophage colony stimulating factor (2908) 2908
activation (2819) 2819
analysis (2743) 2743
cells (2695) 2695
gene expression (2633) 2633
cancer (2626) 2626
monocytes (2514) 2514
macrophage (2507) 2507
biochemistry & molecular biology (2442) 2442
gm-csf (2433) 2433
article (2364) 2364
granulocyte-macrophage colony-stimulating factor (2323) 2323
aged (2289) 2289
differentiation (2276) 2276
macrophages - drug effects (2178) 2178
research article (2174) 2174
proteins (2165) 2165
health aspects (2148) 2148
flow cytometry (2144) 2144
medicine, research & experimental (2071) 2071
macrophages - cytology (2003) 2003
apoptosis (1984) 1984
multidisciplinary sciences (1960) 1960
cell line (1924) 1924
signal transduction (1906) 1906
cell differentiation (1801) 1801
medicine (1774) 1774
in-vitro (1772) 1772
in-vivo (1701) 1701
dendritic cells - immunology (1688) 1688
mice, inbred balb c (1657) 1657
t-cells (1657) 1657
bone marrow (1656) 1656
immune system (1650) 1650
physiological aspects (1641) 1641
lymphocytes (1625) 1625
tumor-necrosis-factor (1600) 1600
rodents (1574) 1574
t cells (1566) 1566
immunotherapy (1564) 1564
immune response (1531) 1531
gene-expression (1492) 1492
mice, knockout (1479) 1479
cytokines - metabolism (1463) 1463
rats (1460) 1460
disease models, animal (1400) 1400
time factors (1368) 1368
cell differentiation - drug effects (1367) 1367
stem cells (1363) 1363
care and treatment (1336) 1336
pharmacology & pharmacy (1336) 1336
science (1336) 1336
granulocyte-macrophage colony-stimulating factor - therapeutic use (1309) 1309
granulocyte colony-stimulating factor (1302) 1302
granulocyte-macrophage colony-stimulating factor - metabolism (1296) 1296
receptor (1278) 1278
macrophages - pathology (1273) 1273
phagocytosis (1256) 1256
monocytes - immunology (1253) 1253
neutrophils (1248) 1248
tumors (1247) 1247
monocytes - metabolism (1221) 1221
leukocytes (1217) 1217
macrophages - physiology (1193) 1193
transplantation (1193) 1193
recombinant proteins - pharmacology (1187) 1187
neurosciences (1174) 1174
biology (1172) 1172
immunity (1169) 1169
nf-kappa-b (1168) 1168
enzyme-linked immunosorbent assay (1162) 1162
pathology (1156) 1156
genetic aspects (1131) 1131
phenotype (1131) 1131
disease (1126) 1126
monocytes - cytology (1124) 1124
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32105) 32105
Chinese (140) 140
Japanese (85) 85
German (43) 43
French (34) 34
Polish (33) 33
Russian (30) 30
Spanish (19) 19
Italian (7) 7
Korean (5) 5
Danish (4) 4
Czech (3) 3
Dutch (3) 3
Hungarian (2) 2
Norwegian (2) 2
Portuguese (2) 2
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression: A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
by Meisel, Christian and Schefold, Joerg C and Pschowski, Rene and Baumann, Tycho and Hetzger, Katrin and Gregor, Jan and Weber-Carstens, Steffen and Hasper, Dietrich and Keh, Didier and Zuckermann, Heidrun and Reinke, Petra and Volk, Hans-Dieter
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2009, Volume 180, Issue 7, pp. 640 - 648
Rationale. Sustained sepsis-associated immunosuppression is associated with uncontrolled infection, multiple organ dysfunction, and death. Objectives: In the... 
Shock | Sepsis | Immunoparalysis | HLA-DR | Immune system | UNITED-STATES | DIAGNOSTIC-VALUE | shock | INNATE IMMUNE-RESPONSE | LEUKOCYTE ANTIGEN-DR | SEVERE TRAUMA | CLASS-II EXPRESSION | SYSTEMIC INFLAMMATION | SEPTIC SHOCK PATIENTS | RESPIRATORY SYSTEM | ENDOTOXIN TOLERANCE | immune system | immunoparalysis | CRITICALLY-ILL PATIENTS | sepsis | CRITICAL CARE MEDICINE | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | HLA-DR Antigens - blood | Male | Sepsis - complications | Shock, Septic - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Flow Cytometry | Immune Tolerance - immunology | Shock, Septic - blood | Female | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Length of Stay - statistics & numerical data | Immune Tolerance - drug effects | Severity of Illness Index | Sepsis - immunology | Double-Blind Method | Shock, Septic - complications | Treatment Outcome | Biomarkers - blood | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Respiration, Artificial - statistics & numerical data | HLA-DR Antigens - immunology | Sepsis - blood | HLA-DR Antigens - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans
by Banks, William A and Dohi, Kenji and Hansen, Kim and Thompson, Hilaire J
Brain, Behavior, and Immunity, ISSN 0889-1591, 2015, Volume 52, pp. 81 - 87
Highlights • Of 23 cytokines, only G-CSF increased in mice after controlled cortical impact. • Serum G-CSF levels correlated with the levels of several brain... 
Psychiatry | Allergy and Immunology | Neuroinflammation | Biomarker | Traumatic brain injury | G-CSF | Blood–brain barrier | Blood-brain barrier | SEVERITY SCORE | CYTOKINES | PSYCHIATRY | INTERLEUKIN-1-BETA | BARRIER | MODEL | IMMUNOLOGY | Blood brain barrier | NEUROSCIENCES | IMMUNE | INTRACEREBROVENTRICULAR INJECTION | Age Factors | Humans | Mice, Inbred C57BL | Middle Aged | Granulocyte Colony-Stimulating Factor - blood | Male | Biomarkers - blood | Blood-Brain Barrier - metabolism | Brain - metabolism | Young Adult | Pilot Projects | Animals | Aged, 80 and over | Adult | Female | Aged | Mice | Brain Injuries, Traumatic - blood | Cytokines - blood | Disease Models, Animal | Brain | Macrophage colony stimulating factor | Granulocyte colony-stimulating factor | Injuries | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma
by Son, Bo-Kyung and Sawaki, Daigo and Tomida, Shota and Fujita, Daishi and Aizawa, Kenichi and Aoki, Hiroki and Akishita, Masahiro and Manabe, Ichiro and Komuro, Issei and Friedman, Scott L and Nagai, Ryozo and Suzuki, Toru
Nature Communications, ISSN 2041-1723, 04/2015, Volume 6, Issue 1, p. 6994
Aortic dissection and intramural haematoma comprise an aortopathy involving separation of the aortic wall. Underlying mechanisms of the condition remain... 
ATHEROSCLEROTIC LESIONS | ACTIVATED MOUSE MACROPHAGES | DISSECTION | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | ANEURYSMS | GROWTH | ANGIOTENSIN-II | ENDOCYTOSIS | CONTRIBUTES | PROGRESSION | Proto-Oncogene Proteins - metabolism | Up-Regulation | Kruppel-Like Factor 6 | Humans | Mice, Inbred C57BL | Middle Aged | Hematoma - etiology | Male | Proto-Oncogene Proteins - genetics | Aortic Aneurysm - etiology | Case-Control Studies | Mice, Knockout | Animals | Aortic Aneurysm - blood | Kruppel-Like Transcription Factors - metabolism | Aged, 80 and over | Adult | Female | Aged | Aneurysm, Dissecting - blood | Kruppel-Like Transcription Factors - genetics | Aneurysm, Dissecting - etiology | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Hematoma - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A randomized Trial of recombinant human granulocyte-macrophage colony stimulating factor for Patients with acute lung injury
by Paine, Robert and Standiford, Theodore J and Dechert, Ronald E and Moss, Marc and Martin, Gregory S and Rosenberg, Andrew L and Thannickal, Victor J and Burnham, Ellen L and Brown, Morton B and Hyzy, Robert C
Critical Care Medicine, ISSN 0090-3493, 01/2012, Volume 40, Issue 1, pp. 90 - 97
Rationale: Despite recent advances in critical care and ventilator management, acute lung injury and acute respiratory distress syndrome continue to cause... 
Acute respiratory distress syndrome | Innate immunity | Sepsis | Growth factors | CELLS | growth factors | ACUTE RESPIRATORY-DISTRESS | CLINICAL-TRIAL | innate immunity | GM-CSF | acute respiratory distress syndrome | QUALITY-OF-LIFE | OUTCOMES | SURVIVORS | sepsis | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Double-Blind Method | Granulocyte-Macrophage Colony-Stimulating Factor - analysis | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Male | Treatment Outcome | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Respiration, Artificial | Interleukin-6 - blood | Female | Acute Lung Injury - drug therapy | Bronchoalveolar Lavage Fluid - chemistry | Infusions, Intravenous | Interleukin-8 - blood | Granulocyte-Macrophage Colony-Stimulating Factor - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inhaled Granulocyte/Macrophage-Colony Stimulating Factor as Therapy for Pulmonary Alveolar Proteinosis
by Tazawa, Ryushi and Trapnell, Bruce C and Inoue, Yoshikazu and Arai, Toru and Takada, Toshinori and Nasuhara, Yasuyuki and Hizawa, Nobuyuki and Kasahara, Yasunori and Tatsumi, Koichiro and Hojo, Masayuki and Ishii, Haruyuki and Yokoba, Masanori and Tanaka, Naohiko and Yamaguchi, Etsuro and Eda, Ryosuke and Tsuchihashi, Yoshiko and Morimoto, Konosuke and Akira, Masanori and Terada, Masaki and Otsuka, Junji and Ebina, Masahito and Kaneko, Chinatsu and Nukiwa, Toshihiro and Krischer, Jeffrey P and Akazawa, Kohei and Nakata, Koh
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2010, Volume 181, Issue 12, pp. 1345 - 1354
Rationale: Inhaled granulocyte/macrophage-colony stimulating factor (GM-CSF) is a promising therapy for pulmonary alveolar proteinosis (PAP) but has not been... 
AUTOANTIBODIES | IMMUNITY | DEFICIENT MICE | RESPIRATORY SYSTEM | WHOLE LUNG LAVAGE | CRITICAL CARE MEDICINE | Enzyme-Linked Immunosorbent Assay - methods | Pulmonary Alveolar Proteinosis - drug therapy | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Prospective Studies | Humans | Japan | Middle Aged | Pulmonary Alveolar Proteinosis - diagnostic imaging | Administration, Inhalation | Tomography, X-Ray Computed - methods | Male | Treatment Outcome | Lung - diagnostic imaging | Pulmonary Alveolar Proteinosis - blood | Biomarkers - blood | Recombinant Proteins | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Dose-Response Relationship, Drug | Adult | Female | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Cohort Studies | C. Critical Care
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text First-in-human study of AMG 820, a monoclonal anti-colony-stimulating factor 1 receptor antibody, in patients with advanced solid tumors
by Papadopoulos, Kyriakos P and Gluck, Larry and Martin, Lainie P and Olszanski, Anthony J and Tolcher, Anthony W and Ngarmchamnanrith, Gataree and Rasmussen, Erik and Amore, Benny M and Nagorsen, Dirk and Hill, John S and Stephenson, Joe
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5703 - 5710
Purpose: Binding of colony-stimulating factor 1 (CSF1) ligand to the CSF1 receptor (CSF1R) regulates survival of tumor-associated macrophages, which generally... 
METASTASIS | INHIBITION | ONCOLOGY | IMMUNOTHERAPY | MACROPHAGES | BLOCKADE | CSF-1 | ADOPTIVE CELL TRANSFER | CANCER | EXPRESSION | PROGRESSION | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Interleukin-1 - blood | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor - blood | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Treatment Outcome | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasms - drug therapy | Antibodies, Monoclonal - blood | Dose-Response Relationship, Drug | Maximum Tolerated Dose | Macrophage Colony-Stimulating Factor - blood | Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Aged, 80 and over | Female | Aged | Macrophage Colony-Stimulating Factor - genetics | Neoplasms - pathology | Alkaline phosphatase | Intravenous administration | Toxicity | Macrophages | Anticancer properties | Quality | Safety engineering | Colony-stimulating factor | Binding | Edema | Deafness | Pharmacodynamics | Cell survival | Colonies | Macrophage colony-stimulating factor | Fatigue | Nausea | Pharmacology | Disease control | Patients | Immunosuppression | Experimental design | Antitumor activity | Ligands | Aspartate aminotransferase | Receptor mechanisms | Solid tumors | Pharmacokinetics | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Colony-stimulating factor-1: A potential biomarker for lupus nephritis
by Menke, Julia and Amann, Kerstin and Cavagna, Lorenzo and Blettner, Maria and Weinmann, Arndt and Schwarting, Andreas and Kelley, Vicki R
Journal of the American Society of Nephrology, ISSN 1046-6673, 02/2015, Volume 26, Issue 2, pp. 379 - 389
A noninvasive means to predict the onset and recurrence of lupus nephritis (LN) before overt renal injury is needed to optimize and individualize treatment.... 
REPAIR | TUBULOINTERSTITIAL LESIONS | PREDICTORS | MACROPHAGE | DISEASE | UROLOGY & NEPHROLOGY | PROLIFERATION | GELATINASE-ASSOCIATED LIPOCALIN | CSF-1 | ASSOCIATION | ERYTHEMATOSUS | Predictive Value of Tests | Biomarkers - urine | Humans | Middle Aged | Kidney Glomerulus - physiopathology | Male | Case-Control Studies | Macrophage Colony-Stimulating Factor - urine | Lupus Nephritis - blood | Young Adult | Adult | Female | Retrospective Studies | Kidney Tubules - pathology | Kidney Tubules - metabolism | Severity of Illness Index | Reproducibility of Results | Biomarkers - blood | Disease Progression | Macrophage Colony-Stimulating Factor - blood | Biopsy | Adolescent | Lupus Nephritis - urine | Aged | Longitudinal Studies | Lupus Nephritis - diagnosis | macrophages | rheumatology | kidney disease | lupus nephritis | glomerulonephritis | renal tubular epithelial cells | Basic Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Use of a biosimilar granulocyte colony‐stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftment
by Publicover, Amy and Richardson, Deborah S and Davies, Andrew and Hill, Kate S and Hurlock, Carol and Hutchins, David and Jenner, Matthew W and Johnson, Peter W and Lamb, Jane and Launders, Harriet and McKeag, Nikki and Newman, Joan and Orchard, Kim H
British Journal of Haematology, ISSN 0007-1048, 07/2013, Volume 162, Issue 1, pp. 107 - 111
Summary Peripheral blood haematopoietic progenitor cell mobilization has become a standard procedure prior to autologous stem cell transplantation. Biosimilar... 
granulocyte colony‐stimulating factor | engraftment | stem cell harvest | mobilization | biosimilar | Engraftment | Mobilization | Granulocyte colony-stimulating factor | Biosimilar | Stem cell harvest | ANTIBODIES | EXPERIENCE | granulocyte colony-stimulating factor | HEMATOLOGY | TRANSPLANTATION | Hematopoietic Stem Cells - drug effects | Antigens, CD34 - metabolism | Hematopoietic Stem Cell Mobilization - methods | Humans | Middle Aged | Male | Transplantation, Autologous | Hematopoietic Stem Cells - metabolism | Biosimilar Pharmaceuticals - pharmacology | Young Adult | Granulocyte Colony-Stimulating Factor - pharmacology | European Union | Hematopoietic Stem Cells - cytology | Adolescent | Adult | Female | Aged | Retrospective Studies | Graft Survival - drug effects | Peripheral Blood Stem Cell Transplantation | Usage | Macrophage colony stimulating factor | Analysis | Hematopoietic stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text IL‐34 and macrophage colony‐stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells
by Preisser, Laurence and Miot, Charline and Guillou‐Guillemette, Hélène and Beaumont, Elodie and Foucher, Etienne D and Garo, Erwan and Blanchard, Simon and Frémaux, Isabelle and Croué, Anne and Fouchard, Isabelle and Lunel‐Fabiani, Françoise and Boursier, Jérôme and Roingeard, Philippe and Calès, Paul and Delneste, Yves and Jeannin, Pascale
Hepatology, ISSN 0270-9139, 12/2014, Volume 60, Issue 6, pp. 1879 - 1890
Chronic hepatitis C virus (HCV) infection is characterized by progressive hepatic fibrosis, a process dependent on monocyte recruitment and accumulation into... 
UNITED-STATES | VIRAL INTERACTIONS | MORTALITY | B-VIRUS | HEPATOCELLULAR-CARCINOMA | COINFECTED PATIENTS | CHRONIC LIVER-DISEASE | RISK | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | DUAL INFECTION | Killer Cells, Natural - secretion | Cell Line | Hepatitis C, Chronic - metabolism | Liver Cirrhosis - immunology | Interleukins - blood | Humans | Interferon-gamma - secretion | Middle Aged | Hepatic Stellate Cells - metabolism | Male | Hepatitis C, Chronic - complications | Hepatocytes - metabolism | Interleukin-13 - metabolism | Case-Control Studies | Collagen Type I - biosynthesis | Macrophage Colony-Stimulating Factor - blood | Liver Cirrhosis - metabolism | Adult | Female | Aged | Matrix Metalloproteinase 1 - metabolism | Hepatitis | Liver cirrhosis | Collagen | Chemokines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
by Leisha A. Emens and Justin M. Asquith and James M. Leatherman and Barry J. Kobrin and Silvia Petrik and Marina Laiko and Joy Levi and Maithili M. Daphtary and Barbara Biedrzycki and Antonio C. Wolff and Vered Stearns and Mary L. Disis and Xiaobu Ye and Steven Piantadosi and John H. Fetting and Nancy E. Davidson and Elizabeth M. Jaffee
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 5911 - 5918
Purpose Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccines have demonstrated bioactivity but may be limited by disease burdens... 
AUTOLOGOUS MELANOMA-CELLS | METASTATIC MELANOMA | LUNG-CANCER | ONCOLOGY | PROSTATE-CANCER | PANCREATIC-CANCER | REGULATORY T-CELLS | PERIPHERAL-BLOOD | CELLULAR IMMUNOTHERAPY | ANTITUMOR IMMUNITY | GENE-TRANSFER | Breast Neoplasms - secondary | Cyclophosphamide - administration & dosage | Breast Neoplasms - immunology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - therapy | CD4-Positive T-Lymphocytes - immunology | Cancer Vaccines - genetics | Dose-Response Relationship, Drug | Transfection | Granulocyte-Macrophage Colony-Stimulating Factor - biosynthesis | Time Factors | Adult | Female | Immunization Schedule | Receptor, ErbB-2 - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Doxorubicin - administration & dosage | Cell Line | Drug Administration Schedule | Immunotherapy, Adoptive | Cancer Vaccines - administration & dosage | Cancer Vaccines - adverse effects | Treatment Outcome | Combined Modality Therapy | Breast Neoplasms - drug therapy | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Index Medicus | Original Reports | Bc8 | To6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal crohn's disease
by Gathungu, Grace and Zhang, Yuanhao and Tian, Xinyu and Bonkowski, Erin and Rowehl, Leahana and Krumsiek, Julia and Nix, Billy and Chalk, Claudia and Trapnell, Bruce and Zhu, Wei and Newberry, Rodney and Denson, Lee and Li, Ellen
World Journal of Gastroenterology, ISSN 1007-9327, 02/2018, Volume 24, Issue 5, pp. 623 - 630
AIM to examine the relationship between elevated granulocyte-macrophage colony-stimulating factor (GMCSF) auto-antibodies (Ab) level and time to surgical... 
Inflammatory bowel disease | Granulocytemacrophage colony-stimulating factor antibody | Crohn's disease | Surgery | FACTOR AUTOANTIBODIES | INFLAMMATORY-BOWEL-DISEASE | FACTOR GM-CSF | COHORT | Granulocyte-macrophage colony-stimulating factor antibody | SARGRAMOSTIM | GASTROENTEROLOGY & HEPATOLOGY | Crohn Disease - genetics | Recurrence | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Ileal Diseases - surgery | Autoantibodies - blood | Humans | Middle Aged | Crohn Disease - surgery | Male | Ileum - immunology | Time Factors | Adult | Female | Ileal Diseases - genetics | Retrospective Studies | Ileal Diseases - immunology | Autophagy-Related Proteins - genetics | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Risk Assessment | Biomarkers - analysis | Crohn Disease - immunology | Ileal Diseases - blood | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Crohn Disease - blood | Ileum - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies
by Hamadani, Mehdi and Kochuparambil, S. Thomas and Osman, Salman and Cumpston, Aaron and Leadmon, Sonia and Bunner, Pamela and Watkins, Kathy and Morrison, Devi and Speir, Ethan and DeRemer, David and Kota, Vamsi and Jillella, Anand and Craig, Michael and Awan, Farrukh
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 7, pp. 1128 - 1135
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide (ID-CY) and granulocyte colony-stimulating factor (G-CSF) has been shown... 
Hematology, Oncology and Palliative Medicine | High dose therapy | Lenalidomide | Autologous transplantation | Chemomobilization | PROGENITOR CELLS | COLLECTION | LENALIDOMIDE THERAPY | OVERCOMES | IMMUNOLOGY | G-CSF | CHEMOTHERAPY | TRANSPLANTATION | AGENTS | HEMATOLOGY | Neutrophils - cytology | Cyclophosphamide - administration & dosage | Blood Platelets - immunology | Drug Administration Schedule | Hematopoietic Stem Cell Mobilization - methods | Humans | Middle Aged | Neutrophils - immunology | Hematopoietic Stem Cell Transplantation | Male | Multiple Myeloma - immunology | Transplantation, Autologous | Thalidomide - administration & dosage | Remission Induction | Thalidomide - analogs & derivatives | Drug Dosage Calculations | Multiple Myeloma - therapy | Antigens, CD34 - immunology | Blood Platelets - cytology | Treatment Failure | Adult | Female | Aged | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Cyclophosphamide | Chemotherapy | Granulocyte colony-stimulating factor | Multiple myeloma | Stem cells | Dosage and administration | Transplantation | Macrophage colony stimulating factor | Hematopoietic stem cells | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
by Su, Shicheng and Su, Fengxi and Liu, Qiang and Chen, Jianing and Chen, Jingqi and Chen, Fei and He, Chonghua and Huang, Wei and Huang, Di and Wu, Wei and Lin, Ling and Zhang, Jin and Cui, Xiuying and Zheng, Fang and Li, Haiyan and Yao, Herui and Song, Erwei
Cancer Cell, ISSN 1535-6108, 05/2014, Volume 25, Issue 5, pp. 605 - 620
The close vicinity of cancer cells undergoing epithelial-mesenchymal transition (EMT) and tumor-associated macrophages (TAMs) at the invasive front of tumors... 
MYELOID SUPPRESSOR-CELLS | PARACRINE LOOP | INVASION | COLONY-STIMULATING FACTOR | ONCOLOGY | GM-CSF | MELANOMA VACCINE | TUMOR-ASSOCIATED MACROPHAGES | NF-KAPPA-B | ESTROGEN-RECEPTOR | T-CELLS | CELL BIOLOGY | Neoplasm Transplantation | Chemokines, CC - blood | Macrophages - pathology | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Humans | Mesoderm - cytology | Mice, SCID | Breast Neoplasms - metabolism | Chemokines, CC - antagonists & inhibitors | Feedback, Physiological | Neoplasm Metastasis | Animals | MCF-7 Cells | Breast Neoplasms - pathology | Epithelial-Mesenchymal Transition | Cell Line, Tumor | Breast Neoplasms - mortality | Female | Granulocyte-Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Mice, Inbred NOD | Mice | Granulocyte-Macrophage Colony-Stimulating Factor - blood | Macrophages - immunology | Chemokines, CC - metabolism | Breast cancer | Metastasis | Macrophages | Cancer cells | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure
by Kulkarni, Shilpa and Singh, Pankaj K and Singh, Vijay K and Ghosh, Sanchita P and Posarac, Ana
Cytokine, ISSN 1043-4666, 05/2013, Volume 62, Issue 2, pp. 278 - 285
This study aimed to determine the role of granulocyte colony-stimulating factor (G-CSF), induced by a promising radiation countermeasure, gamma tocotrienol... 
Hematopoietic tissue | Gamma tocotrienol | Mice | Gamma radiation | Radioprotection | TOTAL-BODY IRRADIATION | PROGENITOR CELLS | MULTILINEAGE HEMATOPOIETIC RECOVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PERIPHERAL-BLOOD | IMMUNOLOGY | INDUCED MYELOSUPPRESSION | CELL BIOLOGY | NONHUMAN PRIMATE MODEL | FACTOR G-CSF | RECEPTOR AGONIST | SUPEROXIDE-DISMUTASE | TOCOPHEROL SUCCINATE | Antibodies, Neutralizing | Granulocyte Colony-Stimulating Factor - blood | Vitamin E - analogs & derivatives | Male | Whole-Body Irradiation - adverse effects | Animals | Chromans - pharmacology | Radiation Injuries - prevention & control | Antibodies - immunology | Radiation-Protective Agents - pharmacology | Granulocyte Colony-Stimulating Factor - immunology | Vitamin E - pharmacology | Viral antibodies | Antibodies | Macrophage colony stimulating factor | Granulocyte colony-stimulating factor | Nuclear radiation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights